Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: In France, the only vaccines available for use as a pertussis booster in adults are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular pertussis and inactivated poliovirus (Tdap-IPV). Adults may require a pertussis booster relatively soon after having received vaccines containing tetanus-diptheria antigens (Td) (occupational or familial circumstances such as new job, childbirth in recent past or future), although the safety of Tdap-IPV when administered soon after vaccination with Td is undocumented. METHODS: In this randomized, double-blind, multi-centre study, we assessed the safety of Tdap-IPV administered one month after vaccination with tetanus, diphtheria (adult formulation), inactivated poliovirus vaccination (Td-IPV) in healthy adults vaccinated according to the French vaccination calendar (seven tetanus-diphtheria vaccinations by age 18 years). Subjects received either Td-IPV (n = 249) or placebo (n = 251) followed 1 month later by Tdap-IPV. Any adverse events (AEs) were recorded. RESULTS: The safety of Tdap-IPV was similar when Tdap-IPV vaccine was administered one month after either Td-IPV or placebo: at seven days, 85.1% versus 93.4% subjects reported at least one reaction at the injection site, mainly pain (82.6% versus 92.1%); 40.5% versus 45.0%, at least one systemic AE (mainly headache: 26.4% versus 26.0%); fever concerned 1.7% of both groups. No serious vaccine-related AEs were reported. Both safety profiles corresponded to documented product characteristics. CONCLUSIONS: Tdap-IPV may be administered to adults one month after Td-IPV without exacerbating post-vaccination side-effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Liang, J. L., Tiwari, T., Moro, P., Messonnier, N. E., Reingold, A., Sawyer, M., & Clark, T. A. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6702a1 · Cited by 457
Adverse reactions to vaccines practice parameter 2012 update
Kelso, J. M., Greenhawt, M. J., Li, J. T., Nicklas, R. A., Bernstein, D. I., Blessing-Moore, J., Cox, L., Khan, D., Lang, D. M., Oppenheimer, J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.003 · Cited by 293
Havers, F. P., Moro, P. L., Hunter, P., Hariri, S., & Bernstein, H. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6903a5 · Cited by 217
Ridda, I., Yin, J. K., King, C., Raina MacIntyre, C., & McIntyre, P. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.08.079 · Cited by 48
Metadata
- Authors
- Beytout, J., Launay, O., Guiso, N., Fiquet, A., Baudin, M., Richard, P., Baptiste, C., & Soubeyrand, B.
- Venue
- Human Vaccines
- Publisher
- Informa UK Limited
- Published
- 2009-05
- Volume
- 5
- Issue
- 5
- Pages
- 315-321
- ISSN
- 1554-8600 (ISSN-L)
- 1554-8619
- OpenAlex
- W2086108742
- Cited by
- 75
- References
- 0
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial. https://app.cochat.ai/papers/10.4161/hv.5.5.6911
- The paper
- Beytout, J., Launay, O., Guiso, N., Fiquet, A., Baudin, M., Richard, P., Baptiste, C., & Soubeyrand, B. (2009). Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial. Human Vaccines. https://doi.org/10.4161/hv.5.5.6911
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.